The Serbian Competition Authority advises the Government to review the list of medicines provided under the national health insurance scheme (Medicines provided under the national health insurance scheme)

On 2 October 2009 Serbian Competition Authority (KZK) [1] issued an opinion concerning the Government's decision to reduce the number of medicines purchased by the medical institutions under the national health insurance scheme. KZK initiated its investigation following a complaint lodged by a law firm that alleged that the new list of the medicines approved under the national insurance scheme restricted competition on the market for pharmaceutical products. The complaint referred to the decision of the Government issued on 7 July 2009 in relation to the measures for stimulation of local drug manufacturing in times of economic recession. Following the initiative launched by the Serbian Chamber of Commerce [2] , the Government decided to support domestic drug

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Alexandr Svetlicinii, The Serbian Competition Authority advises the Government to review the list of medicines provided under the national health insurance scheme (Medicines provided under the national health insurance scheme), 2 October 2009, e-Competitions Bulletin Public procurement, Art. N° 29350

Visites 1153

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues